1430331-42-2

Upstream product

• 13985-43-8 4-hydroxy-3-nitrophenyl benzoate 
• 53939-77-8 4-hydroxy-3-aminophenyl benzoate 
• 1430331-41-1 5-(2-(5-(1,3-dioxolan-2-yl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)-N-(4-chlorophenyl)benzo[d]oxazol-2-amine 
• 1430331-39-7 2-(4-chlorophenylamino)benzo[d]oxazol-5-ol 
• 1430331-37-5 2-(4-chlorophenylamino)benzo[d]oxazol-5-yl benzoate 
• 1430331-35-3 3-(3-(4-Chlorophenyl)thioureido)-4-hydroxyphenyl benzoate 

Downstream Products

• 1430331-45-5 5-(2-(5-((4-aminopiperidin-1-yl)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)-N-(4-chlorophenyl)benzo[d]oxazol-2-amine 
• 1430330-90-7 N-(4-chlorophenyl)-5-(2-(5-((((1-ethyl-1H-1,2,3-triazol-4-yl)methyl)(isopropyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)benzo[d]oxazol-2-amine 
• 1430331-44-4 tert-butyl 1-((6-(7-(2-(4-chlorophenylamino)benzo[d]oxazol-5-yloxy)thieno[3,2-b]pyridin-2-yl)pyridin-3-yl)methyl)piperidin-4-ylcarbamate 
• 1430331-49-9 N-(4-chlorophenyl)-5-(2-(5-((prop-2-ynylamino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)benzo[d]oxazol-2-amine 
• 1430330-82-7 N-(1-((6-(7-(2-(4-chlorophenylamino)benzo[d]oxazol-5-yloxy)thieno[3,2-b]pyridin-2-yl)pyridin-3-yl)methyl)piperidin-4-yl)-2-hydroxyacetamide 
• 1430331-47-7 2-(((6-(7-(2-(4-chlorophenylamino)benzo[d]oxazol-5-yloxy)thieno[3,2-b]pyridin-2-yl)pyridin-3-yl)methyl)piperidin-4-ylamino)-2-oxoethyl acetate 
• 1430330-86-1 4-((6-(7-(2-(4-chlorophenylamino)benzo[d]oxazol-5-yloxy)thieno[3,2-b]pyridin-2-yl)pyridin-3-yl)methyl)amino-N-(2-(diethylamino)ethyl)benzamide 

Relevant academic research and scientific papers

Inhibitors of Protein Tyrosine Kinase Activity

The present invention provides new compounds and methods for treating a disease responsive to inhibition of kinase activity, for example a disease responsive to inhibition of protein tyrosine kinase activity, for example a disease responsive to inhibition of protein tyrosine kinase activity of growth factor receptors, for example a disease responsive to inhibition of receptor type tyrosine kinase signaling, or for example, a disease responsive to inhibition of VEGF receptor signaling.